Skip to main content

Health and medicine/Clinical medicine/Medical treatments

Learn about what it's like to work in science with our series of interviews with STEM professionals.
How DoSER's 'Scientists and Religious Communities' project will unfold in the coming year.

Medical research and treatment increasingly depend on patient participation and new technologies—two critical aspects of modern health care that experts will discuss at a conference co-sponsored by AAAS.

The 6-7 June meeting, “Clinical Trials: New Challenges & Opportunities” will examine the future of scientific studies that work with human volunteers to find new ways to diagnose, screen, prevent, and treat disease. The event is co-sponsored by the National Library of Medicine and the Friends of the National Library of Medicine.

AAAS today expressed strong concerns that a legal ruling blocking federally funded human embryonic stem cell research will badly delay medical progress that could someday save lives and treat devastating injuries and illness.

The uncertainty created by the 23 August ruling of U.S. District Judge Royce C. Lamberth “is bound to be tremendously disruptive to researchers endeavoring to advance human embryonic stem cell research to improve human quality of life,” said Albert Teich, director of Science and Policy Programs at AAAS.